doi: 10.1111/j.1365-2826.2008.01814.x 80 RichardCDTolleVLowMJ
However, one study of severely underweight women with anorexia found that carnitine supplements did not raise levels of this amino acid in the blood nor did it improve muscle weakness
It's an investigational drug currently in Phase 3 clinical trials Eli Lilly's TRIUMPH Phase 3 program includes multiple trials for obesity, type 2 diabetes, NASH, and cardiovascular outcomes Expected timeline: FDA submission in 2026, potential approval in 20272028 Phase 2 results showed 24.2% weight loss at 48 weeks, the highest ever recorded for a GLP-1 class medication How to access now: Clinical trial enrollment (free), compounding pharmacies (with important legal caveats), or research peptides (grey market) When approved, retatrutide will be the first triple-agonist obesity medication (GLP-1 + GIP + glucagon) Is Retatrutide FDA Approved
weight-loss version approved as Zepbound
Semaglutide and tirzepatide are two non-invasive, effective weight loss injections that can help you feel more in control during your journey to a new you